The Toxicology of Perfluorooctanoate

REFERENCES

• Abdellatif, A.G., Preat, V., Taper, H.S., and Roberfroid, M. (1991). The modulation of rat liver carcinogen-esis by perfluorooctanoic acid, a peroxisome proliferator. Toxicol. Appl. Pharmacol. 111:530–537.
   PubMedGoogle Scholar
• Alexander, B.H. (2001). Mortality study of workers employed at the 3M Cottage Grove facility. St. Paul, MN: 3M Company. U.S. EPA Public Docket AR-226-1030a018, Washington, D.C.
   Google Scholar
• Alexander, B.H., Olsen, G.W., Burris, J.M., Mandel, J.H., and Mandel, J.S. (2003). Mortality of employees of a perfluorooctanesulphonyl fluoride manufacturing facility. Occup. Environ. Med. 60:722–729.
   PubMed Web of Science ®Google Scholar
• Anderson, K.E., Potter, J.D., and Mack, T.M. (1996). Pancreatic cancer. In Cancer epidemiology and prevention, eds. O. Schottenfeld and J. Fraumeni, pp. 725–771. New York: Oxford University Press.
   Google Scholar
• Armstrong, F.H., and Lowe, K.C. (1989). Effects of emulsified perfluorochemicals on liver CYP450 in rats. Comp. Biochem. Physiol. 94C:345–349.
   Google Scholar
• Ashby, J., and LeFevre, P.A. (2000). The peripubertal male rat assay as an alternative to the Hershberger castrated male rat assay for the detection of anti-androgens, oestrogens, and metabolic modulators. J. Appl. Toxicol. 20:35–47.
   PubMed Web of Science ®Google Scholar
• Ashby, J., Brady, A., Elcombe, C.R., Elliott, B.M., Ishmael, J., Odum, J., Tugwood, J.D., Kettle, S., and Purchase, I.F.H. (1994). Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis. Hum. Exp. Toxicol. 13(suppl. 2):S1–S117.
   PubMedGoogle Scholar
• Belisle, J., and Hagen, D. (1980). A method for determination of perfluorooctanoic acid in blood and other biological samples. Anal. Biochem. 101:369–376.
   PubMed Web of Science ®Google Scholar
• Bentley, P., Calder, I., Elcombe, C., Grasso, P., Stringer, D., and Wiegand, H.-J. (1993). Hepatic peroxisome proliferation in rodents and its significance for humans. Food Chem. Toxicol. 31:857–907.
   PubMed Web of Science ®Google Scholar
• Berthiaume, J., and Wallace, K.B. (2002). Perfluorooctanoate, perfluorooctane sulfonate, and (*)-ethylperfluorooctanesulfonamido ethanol; Peroxisome proliferation and mitochondrial biogenenesis. Toxicol. Lett. 129:23–32.
   PubMed Web of Science ®Google Scholar
• Biegel, L.B., Liu, R.C.M., Hurtt, M.E., and Cook, J.C. (1995). Effects of ammonium perfluorooctanoate on Leydig cell function: (*), and (*) studies. Toxicol. Appl. Pharmacol. 134:18–25.
   PubMed Web of Science ®Google Scholar
• Biegel, L.B., Hurtt, M.E., Frame, S.R., O’Connor, J.C., and Cook, J.C. (2001). Mechanisms of extrahepatic tumor induction by peroxisome proliferators in male CD rats. Toxicol. Sci. 60:44–55.
   PubMed Web of Science ®Google Scholar
• Burris, J.M., Lundberg, J.K., Olsen, G., Simpson, C., and Mandel, J. (2002). Interim report No. 2, Determination of serum half-lives of several fluorochemicals. St. Paul (MN), 3M Company. U.S. EPA Public Docket AR-226.
   Google Scholar
• Butenhoff, J., Costa, G., Elcombe, C., Farrar, D., Hansen, K., Iwai, H., Jung, R., Kennedy, G., Lieder, P., Olsen, G., and Thomford, P. (2002). Toxicity of ammonium perfluorooctanoate (APFO) in male cynomolgus monkeys after oral dosing for six months. Toxicol. Sci. 69:244–257.
   PubMed Web of Science ®Google Scholar
• Butenhoff, J.L., Gaylor, D.W., Moore, J.A., Olsen, G.W., Rodricks, J., Mandel, J.H., and Zobel, L.R. (2004a). Characterization of risk for general population exposure to perfluorooctanoate. Regul. Tox. Pharmacol. 39:363–380.
   PubMed Web of Science ®Google Scholar
• Butenhoff, J.L., Kennedy, G.L., Frame, S.R., O’Connor, J.C., and York, R.G. (2004b). The reproductive toxicology of ammonium perfluorooctanoate (APFO) in the rats. Toxicology 196:95–116.
   PubMed Web of Science ®Google Scholar
• Cameron, R.G., Imaida, K., Tsuda, H., and Ito, N. (1982). Promotive effects of steroids and bile acids on hepatocarcinogenesis initiated by diethylnitrosamine. Cancer Res. 42:2426–2428.
   PubMed Web of Science ®Google Scholar
• Carney, E.W., Scortichini, B.S., and Crissman, J.W. (1998). Feed restriction during (*) and neonatal life: Effects on reproductive and developmental endpoints in the CD rat. Toxicologist 42:102–103.
   Google Scholar
• Cattley, R.C., DeLuca, J., Elcombe, C., Fenner-Crisp, P., Lake, B.G., Marsman, D.S., Pastoor, T.A., Popp, J.A., Robinson, D.E., Schwetz, B., Tugwood, J., and Wahli, W. (1998). Do peroxisome proliferating compounds pose a hepatocarcinogenic hazard to humans. Regul. Toxicol. Pharmacol. 27:47–60.
   Web of Science ®Google Scholar
• Christian, M.S., McCarty, R.J., Cox-Sica, D.K., and Cao, C.P. (1987). Recent increases in the incidences of skull, lung and rib alterations in vehicle control New Zealand white rabbits. J. Am. Coll. Toxicol. 6:562.
   Google Scholar
• Clark, R.L. (1999). Endpoints of reproductive system development. In An evaluation and interpretation of reproductive endpoints for human risk assessment, pp. 27–62. Washington, DC: International Life Sciences Institute, Health and Environmental Science Institute.
   Google Scholar
• Clegg, E.D., Cook, J.C., Chapin, R.E., Foster, P., and Daston, G.P. (1997). Leydig cell hyperplasia and adenoma formation: Mechanisms and relevance to humans (abstract). Reprod. Toxicol. 11:107–121.
   PubMed Web of Science ®Google Scholar
• Cook, J.C., Murray, S.M., Frame, S.R., and Hurtt, M.E. (1992). Induction of Leydig cell adenomas by ammonium perfluorooctanoate: A possible endocrine-related mechanism. Toxicol. Appl. Pharmacol. 113:209–217.
   PubMed Web of Science ®Google Scholar
• Cook, J.C., Hurtt, M.E., Frame, S.R., and Biegel, L.B. (1994). Mechanisms of extrahepatic tumor induction by peroxisome proliferators in Crl:CD R®BR (CD) rats. Toxicologist 14:301.
   Google Scholar
• Cook, J.C., Klinefelter, G.R., Hardisty, J.F., Sharpe, R.M., and Foster, P.M. (1999). Rodent Leydig cell tumorigenesis: A review of the physiology, pathology, mechanisms, and relevance to humans. Crit. Rev. Toxicol. 29:169–261.
   PubMed Web of Science ®Google Scholar
• Corton, J., Bocos, C., Moreno, E., Merritt, A., Cattley, R., and Gustafsson, J.A. (1997). Peroxisome proliferators alter the expression of estrogen-metabolizing enzymes. Biochimie 79:151–162.
   PubMed Web of Science ®Google Scholar
• Davis, J.W. II, Vanden Heuvel, J.P., Kuslikis, B.I., and Peterson, R.E. (1991). Castration increases elimination of perfluorooctanoic acid (PFOA) in male rats. Toxicologist 11:95.
   Google Scholar
• De Pinieux, G., Chariot, P., Ammi-Said, M., Louarn, F., Lejonc, J.L., Astier, A., Jacotot, B., and Gherardi, R. (1996). Lipid-lowering drugs and mitochondrial function: Effects of HMG-CoA reductase inhibitors on serum ubiquinones and blood lac-tate/pyruvate ratio. Br. J. Clin. Pharmacol. 42:333–337.
   PubMedGoogle Scholar
• Doull, J., Cattley, R., Elcombe, E., Lake, B., Swenburg, J., Wilkinson, C., Williams, G., and van Gemert, M. (1999). A cancer risk assessment of di(2-ethylhexyl)phthalate: Application of the new U.S. EPA Risk Assessment Guidelines. Regul. Toxicol. Pharmacol. 29:327–357.
   PubMed Web of Science ®Google Scholar
• DuPont Company. (1965). Effects of fluorocarbon dispersing agents on the livers of rats and dogs. Haskell Laboratory unpublished report. Newark, DE. Available from GLK on request.
   Google Scholar
• DuPont Company. (1979a). Acute dermal toxicity. Haskell Laboratory unpublished report. Newark, DE.
   Google Scholar
• DuPont Company. (1979b). Eye irritation test in rabbits. Haskell Laboratory unpublished report. Newark, DE.
   Google Scholar
• DuPont Company. (1981a). Ammonium perfluorooctanoate blood levels in the female rat. Haskell Laboratory unpublished report. Newark, DE.
   Google Scholar
• DuPont Company. (1981b). Liver weight comparison in castrated and ovariectomized rats vs. normal rats. Haskell Laboratory unpublished report. Newark, DE.
   Google Scholar
• DuPont Company. (1981c). Oral LD₅₀ test in rats. Haskell Laboratory unpublished report. Newark, DE.
   Google Scholar
• DuPont Company. (1981d). Oral LD₅₀ test in rats. Haskell Laboratory unpublished report. Newark, DE.
   Google Scholar
• DuPont Company. (1981e). Oral LD₅₀ test in mice. Haskell Laboratory unpublished report. Newark, DE.
   Google Scholar
• DuPont Company. (1981f). Oral LD₅₀ test in guinea pigs. Haskell Laboratory unpublished report. Newark, DE.
   Google Scholar
• DuPont Company. (1981g). Mouse feeding study—14 day. Haskell Laboratory unpublished report. Newark, DE.
   Google Scholar
• DuPont Company. (1982a). Excretion and disposition of ¹⁴C-ammonium perfluorooctanoate in male and female rats, mice, hamsters, and rabbits. Haskell Laboratory unpublished report. Newark, DE.
   Google Scholar
• DuPont Company. (1982b). Placental transfer of ¹⁴C-labelled C-8 in the rat. Haskell Laboratory unpublished report. Newark, DE.
   Google Scholar
• DuPont Company. (1982c). Effect of cholestyramine in the elimination of 14C-ammonium perfluorooctanoate in rats and mice. Haskell Laboratory unpublished report. Newark, DE.
   Google Scholar
• DuPont Company. (1983a). Acute oral toxicity of FC-143 as a function of age. Haskell Laboratory unpublished report. Newark, DE.
   Google Scholar
• DuPont Company. (1983b). APFO liver weights in rats and mice. Oral administration to males and females. Haskell Laboratory unpublished report. Newark, DE.
   Google Scholar
• Eagon, P.K., Chandar, N., Epley, M.J., Elm, M.S., Brady, E.P., and Rao, K.N. (1994). Di(2-ethylhexyl)phthalate-induced changes in liver estrogen metabolism and hyperplasia. Int. J. Cancer 58:736–743.
   PubMed Web of Science ®Google Scholar
• Eagon, P.K., Elm, M.S., Epley, M.J., , Shinozuka, H., and Rao, K.N. (1996). Sex steroid metabolism and receptor status in hepatic hyperplasia and cancer in rats. Gastroenterology 110:1199–1207.
   PubMedGoogle Scholar
• Elcombe, C.R., Bell, D.R., Elias, E., Hasmall, S.C., and Plant, N.J. (1997). Peroxisome proliferators: Species differences in response of primary hepatocyte cultures. Ann. NY Acad. Sci. 804:628–635.
   Web of Science ®Google Scholar
• Fan, L.Q., Cattley, R.C., and Corton, J.C. (1998). Tissue-specific induction of 17-beta-hydroxysteroid dehydrogenase type IV by peroxisome proliferator chemicals is dependent on the peroxi-some proliferator-activated receptor-alpha. J. Endocrinol. 158:237–246.
   PubMedGoogle Scholar
• Fitzgerald, J.E., Petrere, J.A., and de-la-Iglesia, F.A. (1987). Experimental studies on reproduction with the lipid-regulating agent gemfibrozil. Fundam. Appl. Toxicol. 8:454–464.
   PubMedGoogle Scholar
• Flint, O.P., Masters, B.A., Gregg, R.E., and Durham, S.K. (1997). HMG-CoA reductase inhibitor-induced myotoxicity: Pravastatin and lovastatin inhibit the geranylation of low molecular weight proteins in neonatal rat muscle cell culture. Toxicol. Appl. Pharmacol. 145:99–100.
   PubMed Web of Science ®Google Scholar
• Fosslien, E. (2001). Review: Mitochondrial medicine—molecular pathology of defective oxidative phosphorylation. Ann. Clin. Lab. Sci. 31:25–67.
   PubMed Web of Science ®Google Scholar
• Gavin, C.E., Martin, N.P., and Schlosser, M.J. (1996). Absence of specific CCK-A binding sites on human pancreatic membranes. Toxicologist 30:334.
   Google Scholar
• Gavin, C.E., Malnoske, J.A., White, J., and Schlosser, M.J. (1997). Species differences in expression of pancreatic cholecystokinin-A receptors. Toxicolo-gist 36:1180.
   Google Scholar
• Gibson, S.J., and Johnson, J.D. (1979). Absorption of FC-143-14C in rats after a single oral dose. Riker Laboratories, Inc., Subsidiary of 3M, St. Paul, MN, U.S. EPA Public Docket AR-226-0455, Washington, DC.
   Google Scholar
• Gibson, J.P., Larson, E.J., Yarrington, J.T., Hook, R.H., Kariya, T., and Blohm, T.R. (1981). Toxicity and teratogenicity studies with the hypolipidemic drug RMI 14,514 in rats. Fundam. Appl. Toxicol. 1:19–25.
   PubMedGoogle Scholar
• Gilliland, F.D. (1992). Fluorocarbons and human health: Studies in an occupational cohort. PhD dissertation, University of Minnesota, Minneapolis.
   Google Scholar
• Gilliland, F.D., and Mandel, J.S. (1993). Mortality among employees of a perfluorooctanoic acid production plant. J. Occup. Med. 35:950–954.
   PubMedGoogle Scholar
• Gilliland, F.D., and Mandel, J.S. (1996). Serum perfluorooctanoic acid and hepatic enzymes, lipoproteins, and cholesterol: A study of occupationally exposed men. Am. J. Ind. Med. 29:560–568.
   PubMed Web of Science ®Google Scholar
• Glass, A.R., and Swerdloff, R.S. (1980). Nutritional influences on sexual maturation in the rat. Fed. Proc. 39:2360–2364.
   PubMedGoogle Scholar
• Glass, A.R., Harrison, R., and Swerdloff, R.S. (1976). Effect of undernutrition and amino acid deficiency on the timing of puberty in rats. Pediatr. Res. 10:951–955.
   PubMed Web of Science ®Google Scholar
• Goecke, C.M., Jarnot, B.M., and Reo, N.V. (1992). A comparative toxicological investigation of perfluorocarboxylic acids in rats by fluorine-19 NMR spectroscopy. Chem. Res. Toxicol. 5:512–519.
   PubMed Web of Science ®Google Scholar
• Goecke-Flora, C., and Reo, N. (1996). Influence of carbon chain length on the hepatic effects of perfluorinated fatty acids. Chem. Res. Toxicol. 9:689–695.
   PubMed Web of Science ®Google Scholar
• Gortner, E.G. (1981). Oral teratology study of T-2998CoC in rats. Safety Evaluation Laboratory and Riker Laboratories, Inc., Experiment No. 0681TR0110, December 1981. U.S. EPA Public Docket AR-226-0463.
   Google Scholar
• Gortner, E.G. (1982). Oral teratology study of T-3141CoC in rabbits. Safety Evaluation Laboratory and Riker Laboratories, Inc., Experiment No. 0681TB0398, February 1982. U.S. EPA Public Docket AR-226-0465.
   Google Scholar
• Graham, M.J., Wilson, S.A., Winham, M.A., Spencer, A.J., Rees, J.A., Old, S.L., and Bonner, F.W. (1994). Lack of peroxisome proliferation in marmoset liver following treatment with ciprofibrate for 3 years. Fundam. Appl. Toxicol. 22:58–64.
   PubMedGoogle Scholar
• Green, S. (1995). PPAR: A mediator of peroxisome proliferator action. Mutat. Res. 333:101–109.
   PubMed Web of Science ®Google Scholar
• Griffith, F.D., and Long, J.E. (1980). Animal toxicity studies with ammonium perfluorooctanoate. Am. Ind. Hyg. Assoc. J. 41:576–583.
   PubMed Web of Science ®Google Scholar
• Gross, U., and Rudiger, S. (1991). Perfluorocarbons: Chemically inert but biologically active? (*). 53:155–161.
   Google Scholar
• Guy, W.S. (1973). Fluorocompounds of human plasma: Analysis, prevalence, purification, and characterization. PhD dissertation, University of Rochester, Rochester, NY.
   Google Scholar
• Han, X., Snow, T.A., Kemper, R.A., and Jepson, G.W. (2003). Binding of perfluorooctanoic acid to rat and human plasma proteins. Chem. Res. Toxicol. 16:775–781.
   PubMed Web of Science ®Google Scholar
• Handler, J.A., Seed, C.B., Bradford, B.U., and Thurman, R.G. (1992). Induction of peroxisomes by treatment with perfluorooctanoate does not increase rates of H2O2 production in intact liver. Toxicol. Lett. 60:61–68.
   PubMed Web of Science ®Google Scholar
• Hanhijärvi, H. (1988). A proposed species difference in the renal excretion of perfluorooctanoic acid in the beagle dog and rat. In New developments in biosciences: Their implications for laboratory animal science, eds. A.C. Beynen and H.A. Solleveld, pp. 404–412. Dordrecht: Martinus Nijhoff.
   Google Scholar
• Hanhijärvi, H., Ophaug, R., and Singer, L. (1982). The sex related difference in perfluorooctanoate excretion in the rat. Proc. Soc. Exp. Biol. Med. 171:50–55.
   PubMed Web of Science ®Google Scholar
• Hanhijärvi, H., Ylinen, M., Kojo, A., and Kosma, V. (1987). Elimination and toxicity of perfluorooctanoic acid during subchronic administration in the Wistar rat. Pharmacol. Toxicol. 61:66–68.
   PubMedGoogle Scholar
• Hansen, K.J., Clemen, L.A., Ellefson, M.E., and Johnson, H.O. (2001). Compound-specific, quantitative characterization of organic fluorochemicals in biological matrices. Environ. Sci. Technol. 35(4):766–770.
   PubMed Web of Science ®Google Scholar
• Haughom, B., and Spydevold, O. (1992). The mechanism underlying the hypolipemic effect of perfluorooctanoic acid (PFOA), perfluorooctane sulphonic acid (PFOSA) and clofibric acid. Biochim. Biophys. Acta 1128:65–72.
   PubMed Web of Science ®Google Scholar
• Hazleton, Inc. (1990). Primary dermal irritation/ corrosion study in rabbits. HLA number 91201740. U.S. EPA Public Docket AR-226-0666, Washington, DC.
   Google Scholar
• Hazleton, Inc. (1995a). Mutagenicity test with T-6342 in the Salmonella–E. coli/mammalian microsome reverse mutation assay. Corning Hazleton, Inc. Final Report CHV Study No. 17073-0-409. December 14, 1995. U.S. EPA Public Docket AR-226-0436, Washington, DC.
   Google Scholar
• Hazleton, Inc. (1995b). Mutagenicity test with T-6342 in an in vivo mouse micronucleus assay. Corning Hazleton, Inc. Final Report CHV Study No. 17073-0-455. December 14, (1995). U.S. EPA Public Docket AR-226-0435, Washington, DC.
   Google Scholar
• Hazleton, Inc. (1995c). Acute dermal toxicity study of T-6342 in rabbits. Corning Hazleton, Inc. HWI 50800374. U.S. EPA Public Docket AR-226-0427, Washington, DC.
   Google Scholar
• Hazleton, Inc. (1996a). Mutagenicity test with T-6564 in the Salmonella-E. coli/mammalian microsome reverse mutation assay with a confirmatory assay. Corning Hazleton, Inc. Final Report CHV Study No. 17750-0-409R. September 13, 1996. U.S. EPA Public Docket AR-226-0432, Washington, DC.
   Google Scholar
• Hazleton, Inc. (1996b). Mutagenicity test with T-6342 measuring chromosomal aberrations in cultured whole blood lymphocytes with a confirmatory assay with multiple harvests. Corning Hazleton, Inc. Final Report CHV Study No. 17073-0-449CO. November 1, 1996. U.S. EPA Public Docket AR-226-0433, Washington, DC.
   Google Scholar
• Hazleton, Inc. (1996c). Mutagenicity test with T-6564 measuring chromosomal aberrations in Chinese hamster ovary (CHO) cells with a confirmatory assay with multiple harvests. Corning Hazleton, Inc. Final Report CHV Study No. 17750-0-437CO. September 16, 1996. U.S. EPA Public Docket AR-226.
   Google Scholar
• Hazleton, Inc. (1996d). Mutagenicity test with T-6342 measuring chromosomal aberrations in Chinese hamster ovary (CHO) cells with a confirmatory assay with multiple harvests. Corning Hazleton, Inc. Final Report CHV Study No. 17073-0-437CO. September 16, 1996. U.S. EPA Public Docket AR-226-0434, Washington, DC.
   Google Scholar
• Hazleton, Inc. (1996e). Mutagenicity test with T-6564 in an in vivo mouse micronucleus assay. Corning Hazleton, Inc. Final Report CHV Study No. 17750-0-455, 1996. U.S. EPA Public Docket AR-226-0430, Washington, DC.
   Google Scholar
• Hazleton, Inc. (1997). Acute oral toxicity study of T-6669 in rats. Corning Hazleton, Inc. CHW 61001760. U.S. EPA Public Docket AR-226-0420, Washington, DC.
   Google Scholar
• Herrington, M.K., and Adrian, T.E. (1995). On the role of cholecystokinin in pancreatic cancer. Int. J. Pancreatol. 17:121–138.
   PubMedGoogle Scholar
• Hosokawa, M., and Satoh, T. (1993). Differences in the induction of carboxylesterase isozymes in rat liver microsomes by perfluorinated fatty acids. Xenobiotica 23:1125–1133.
   PubMed Web of Science ®Google Scholar
• IARC. (1995). Peroxisome Proliferation and its role in carcinogenesis. World Health Organization, IARC Technical Report No. 24. Lyon, France.
   Google Scholar
• Ikeda, T., Aiba, K., Fukuda, K., and Tanaka, M. (1985). The induction of peroxisome proliferation in rat liver by perfluorinated fatty acids, metabolically inert derivatives of fatty acids. J. Biochem. 98:475–482.
   PubMed Web of Science ®Google Scholar
• Johnson, J.D., and Ober, R.E. (1980). Extent and route of excretion and tissue distribution of total carbon-14 in male and female rats after a single IV dose of FC-143-¹⁴C. St. Paul, MN,: Riker Laboratories, Inc. U.S. EPA Public Docket AR-226-0457, Washington, DC.
   Google Scholar
• Johnson, J., Gibson, S., and Ober, R. (1984). Cholestyramine-enhanced fecal elimination of carbon-14 in rats after administration of 14C-ammonium perfluorooctanoate or 14C-potassium perfluorooctanesulfonate. Fundam. Appl. Toxicol. 4:972–976.
   PubMedGoogle Scholar
• Just, W.W., Gorgas, K., Hartl, F.U., Heinemann, P., Salzer, M., and Schimassek, H. (1989). Biochemical effects and zonal heterogeneity of peroxisome proliferation induced by perfluorocarboxylic acids in rat liver. Hepatology 9:570–581.
   PubMed Web of Science ®Google Scholar
• Kawashima, Y., Uy-Yu, N., and Kozuka, H. (1989). Sex-related difference in the inductions by perfluorooctanoic acid of peroxisome (*)-oxidation, microsomal 1-acylglycerolphosphocholine acyltransferase and cytosolic long-chain acyl-CoA hydrolase in rat liver. Biochem. J. 261:595–600.
   PubMed Web of Science ®Google Scholar
• Kawashima, Y., Suzuki, S., Kozuka, H., Sato, M., and Suzuki, Y. (1994). Effects of prolonged administration of perfluorooctanoic acid on hepatic activities of enzymes which detoxify peroxide and xenobiotics in the rat. Toxicology 93:85–97.
   PubMedGoogle Scholar
• Keller, B.J., Marsman, D.S., Popp, J.A., and Thurman, R.G. (1992). Several nongenotoxic carcinogens uncouple mitochondrial oxidative phosphorylation. Biochim. Biophys. Acta 1102:237–244.
   PubMed Web of Science ®Google Scholar
• Kennedy, G.C., and Mitra, J. (1963). Body weight and food intake as initiating factors for puberty in the rat. J. Physiol. 166:408–418.
   PubMed Web of Science ®Google Scholar
• Kennedy, G.L., Jr. (1985). Dermal toxicity of ammonium perfluorooctanoate. Toxicol. Appl. Pharmacol. 81:348–355.
   PubMed Web of Science ®Google Scholar
• Kennedy, G.L., Jr. (1987). Increase in mouse liver weight following feeding of ammonium perfluorooctanoate and related fluorochemicals. Toxicol. Lett. 39:295–300.
   PubMed Web of Science ®Google Scholar
• Kennedy, G.L., Jr., Hall, C.T., Brittelli, M.R., Barnes, J.R., and Chen, H.C. (1986). Inhalation toxicity of ammonium perfluorooctanoate. Food Chem. Toxicol. 24:1325–1329.
   PubMed Web of Science ®Google Scholar
• Kerstner-Wood, C., Coward, L., and Gorman, G. (2003). Protein binding of perfluoroobutane sulfonate, perfluorohexane sulfonate, perfluorooctane sulfonate, and perfluorooctanoate to plasma (human, rat, and monkey), and various human-derived plasma protein fractions. Unpublished report, Southern Research Institute, Study 9921.7. U.S. EPA Public Docket AR-226-1354, Washington, DC.
   Google Scholar
• Klaunig, J.E., Babich, M.A., Baetcke, K.P., Cook, J.C., Corton, J.C., David, R.M., DeLuca, J.G., Lai, D.Y., McKee, R.H., Peters, J.M., Roberts, R.A., and Fenner-Crisp, P.A. (2003). PPAR alpha agonist-induced rodent tumors: Modes of action and human relevance. Crit. Rev. Toxicol. 33:655–780.
   PubMed Web of Science ®Google Scholar
• Klevens, H.B., and Ellenbogen, E. (1954). Protein-fluoroacid interaction bovine serum albumin perfluoro-octanoic acid. Discuss. Faraday Soc. 18:277–288.
   Google Scholar
• Kojo, A., Hanhijärvi, H., Ylinen, M., and Kosma, V.M. (1986). Toxicity and kinetics of perfluoro-octanoic acid in the Wistar Rat. Arch. Toxicol. Suppl. 9:465–468.
   PubMedGoogle Scholar
• Kudo, N., Mizuguchi, H., Yamamoto, A., and Kawashima, Y. (1999). Alterations by perfluorooctanoic acid of glycerolipid metabolism in rat liver. Chem. Biol. Interact. 118:69–83.
   PubMedGoogle Scholar
• Kudo, N., Suzuki, E., Katakuva, M., Ohmori, K., Noshiro, R., and Kawashima, Y. (2001). Comparison of elimination between perfluorinated fatty acids with different carbon chain length in rats. Chem.-Biol. Interact. 134:203–216.
   PubMed Web of Science ®Google Scholar
• Kudo, N., Katakura, M., Sato, Y., and Kawashima, Y. (2002). Sex hormone-regulated renal transport of perfluorooctanoic acid. Chem. Biol. Interact. 139:301–316.
   PubMed Web of Science ®Google Scholar
• Kurata, Y., Kidachi, F., Yokoyama, M., Toyota, N., Tsuchitani, M., and Katoh, M. (1998). Subchronic toxicity of di(2-ethylhexyl) phthalate in common marmosets: Lack of peroxisomal proliferation, testicular atrophy, or pancreatic acinar cell hyperplasia. Toxicol. Sci. 42:49–56.
   PubMed Web of Science ®Google Scholar
• Kuslikis, B.I., Vanden Heuvel, J.P., and Peterson, R.E. (1992). Lack of evidence for perfluorodecanoylor perfluorooctanoyl-coenzyme A formation in male and female rats. Biochem. Toxicol. 7:25–29.
   PubMedGoogle Scholar
• Lake, B.G. (1995). Mechanisms of hepatocarcinogenicity of peroxisome-proliferating drugs and chemicals. Annu. Rev. Pharmacol. Toxicol. 35:483–507.
   PubMed Web of Science ®Google Scholar
• Lewis, E.M., Barnett, J.F., Jr., Freshwater, L., Hoberman, A.M., and Christian, M.S. (2002). Sexual maturation data for Crl Sprague-Dawley rats: Criteria and confounding factors. Drug Chem. Toxicol. 25:437–458.
   PubMed Web of Science ®Google Scholar
• Litton Bionetics. (1978). Mutagenic evaluation of T-2015 CoC in the Ames Salmonella microsome plate test. Final Report LBI Project No. 20838, February 1978. U.S. EPA Public Docket AR-226-0429, Washington, DC.
   Google Scholar
• Liu, R.C.M., Hahn, C., and Hurtt, M.E. (1996a). The direct effect of hepatic peroxisome proliferators on rat Leydig cell function (*). Fundam. Appl. Toxicol. 30:102–108.
   PubMedGoogle Scholar
• Liu, R.C.M., Hurtt, M.E., Cook, J.C., and Biegel, L.B. (1996b). Effect of the peroxisome proliferator, ammonium perfluorooctanoate (APFO), on hepatic aromatase activity in adult male Crl:CDBR (CD) rats. Fundam. Appl. Toxicol. 30:220–228.
   PubMedGoogle Scholar
• Liu, S.C., Sanfilippo, B., Perroteau, I., Derynck, E., Salomon, D.S., and Kidwell, W.R. (1987). Expression of transforming growth factor (TGF(*)) in differentiated rat mammary tumors: Estrogen induction of TGF(*) production. Mol. Endocrinol. 1:683–692.
   PubMed Web of Science ®Google Scholar
• Malinverno, G., Rusch, G.M., Millischer, R.J., Hughes, E.W., Schroeder, R.E., and Coombs, D.W. (1996). Inhalation teratology and reproduction studies with 1,1-dichloro-2,2,2-trifluoroethane (HCFC-123). Fundam. Appl. Toxicol. 34:276–287.
   PubMedGoogle Scholar
• Maloney, E.K., and Waxman, D.J. (1999). Trans-activation of PPAR(*) and PPAR(*) by structurally diverse environmental chemicals. Toxicol. Appl. Pharmacol. 161:209–218.
   PubMed Web of Science ®Google Scholar
• Marty, M.S., Crissman, J.W., and Carney, E.W. (1999). Evaluation of the EDSTAC female pubertal assay in CD rats using 17(*)-estradiol, steroid biosynthesis inhibitors, and a thyroid inhibitor. Toxicol. Sci. 52:269–277.
   PubMed Web of Science ®Google Scholar
• Marty, M.S., Crissman, J.W., and Carney E.W. (2001a). Evaluation of the male pubertal onset assay to detect testosterone and steroid biosynthesis inhibitors in CD rats. Toxicol. Sci. 60:285–295.
   PubMedGoogle Scholar
• Marty, M.S., Crissman, J.W., and Carney, E.W. (2001b). Evaluation of the male pubertal onset assay’s ability to detect thyroid inhibitors and dopaminergic agents. Toxicol. Sci. 60:62–76.
   Google Scholar
• Marty, M.S., Johnson, K.A., and Carney, E.W. (2001c). Effect of feed restriction on Hershberger and pubertal male assay endpoints. Toxicologist 60:223.
   Google Scholar
• Moore, G.E. (2001). H-24921: Dermal sensitization test—Buehler method. Product Safety Labs, Study No. 11321. December 17. Dayton, NJ. Available from GLK on request.
   Google Scholar
• Moroi, Y., Yano, H., Shibata, O., and Yonemitsu, T. (2001). Determination of acidity constants of perfluoroalkanoic acids. Bull. Chem. Soc. Jpn. 74:667–672.
   Web of Science ®Google Scholar
• Nilsson, R., Beije, B., Preat, V., Erixon, K. and Ramel, C. (1991). On the mechanism of the hepatocarcinogenicity of peroxisome proliferators. Chem.-Biol. Interact. 78:235–250.
   PubMed Web of Science ®Google Scholar
• Noker, P. (2003). A pharmacokinetic study of potassium perfluorooctanoate in the cynomologus monkey. Southern Research Institute Study ID: 99214. South Research Institute, submitted to U.S. EPA AR 226-1228, Washington, DC.
   Google Scholar
• Nordby, G.L., and Luck, J.M. (1956). Perfluorooctanoic acid interactions with human serum albumin. J. Biol. Chem. 219:399–404.
   PubMed Web of Science ®Google Scholar
• Notox. (2002). Evaluation of the ability of T-7524 to induce chromosomal aberrations in cultured peripheral human lymphocytes. Notox Project No. 292062. Hertogenbosch, the Netherlands. U.S. EPA Public Docket AR-226-0404, Washington, DC.
   Google Scholar
• Obourn, J.D., Frame, S.R., Bell, R.H., Longnecker, D.S., Elliott, G.S., and Cook, J.C. (1997). Mechanisms for the pancreatic oncogenic effects of the peroxisome proliferator Wyeth-14,643. Toxicol. Appl. Pharmacol. 145:425–436.
   PubMed Web of Science ®Google Scholar
• Obraztsov, V.V., Kabalnov, A.S., Makarov, K.N., Gross, U. Radeck, W., and Rudiger, S. (1993). On the interaction of perfluorochemical emulsions with liver microsomal membranes. J. Fluorine Chem. 63:101–111.
   Google Scholar
• Ohmori, K., Kudo, N., Katayama, K., and Kawashima, Y. (2003). Comparison of the toxicokinetics between perfluorocarboxylic acids with different carbon chain length. Toxicology 184:135–140.
   PubMed Web of Science ®Google Scholar
• Ohmura, T., Katyal, S.L., Locker, J., Ledda-Columbano, G.M., Columbano, A., and Shinozuka, H. (1997). Induction of cellular DNA synthesis in the pancreas and kidneys of rats by peroxisome proliferators, 9-(*) retinoic acid, and 3,3′,5-triiodo-l-thyronine. Cancer Res. 57:795–798.
   PubMed Web of Science ®Google Scholar
• Olsen, G.W., Gilliland, F.D., Burlew, M.M., Burris, J.M., Mandel, J.S., and Mandel, J.H. (1998). An epidemiologic investigation of reproductive hormones in men with occupational exposure to perfluorooctanoic acid. J. Occup. Environ. Med. 40:614–620.
   PubMed Web of Science ®Google Scholar
• Olsen, G.W., Burris, J.M., Burlew, M.M., and Mandel, J.H. (2000). Plasma cholecystokinin and hepatic enzymes, cholesterol and lipoproteins in ammonium perfluorooctanoate production workers. Drug Chem. Toxicol. 23:603–620.
   PubMed Web of Science ®Google Scholar
• Olsen, G.W., Church, T., Miller, J.P., Hansen, K.J., Lundberg, J.K., Armitage, J., Herron, R., Medhdizadehkashi, Z., Nobiletti, J., O’Neill, M., Mandel, J.H., and Zobel, L.R. (2003a). Perfluorooctanesulfoante (PFOS) and other fluorochemicals in the serum of American Red Cross adult blood donors. Environ. Health Perspec. 111:1892–1901.
   PubMed Web of Science ®Google Scholar
• Olsen, G.W., Hansen, K.J., Stevenson, L.A., Burris, J.M., and Mandel, J.H. (2003b). Human donor liver and serum concentrations of perfluorooctanesulfonate (PFOS) and other perfluorochemicals. Environ. Sci. Technol. 37:888–891.
   PubMed Web of Science ®Google Scholar
• Olsen, G.W., Butenhoff, J.L., and Mandel, J.H. (2003c). Assessment of lipid, hepatic and thyroid function in relation to an occupational biologic limit value for perfluorooctanoate. U.S. EPA Public Docket AR-226-1351, Washington, DC.
   Google Scholar
• Olsen, G.W., Burris, J.M., Burlew, M.M., and Mandel, J.H. (2003d). Epidemiological assessment of worker serum perfluorooctanesulfoante (PFOS) and perfluorooctanoate (PFOA) concentrations and medical surveillance examinations. J. Occup. Environ. Med. 45:260–270.
   PubMed Web of Science ®Google Scholar
• Olsen, G.W., Church, T.R., Larson, E.B., van Belle, G., Lundberg, J.K., Burris, J.M., Mandel, J.H., and Zobel, L.R. (2004a). Serum concentrations of perfluorooctanesulfonate (PFOS) and other fluoro-chemicals in an elderly population from Seattle, Washington. Chemosphere 54:1599–1611.
   PubMed Web of Science ®Google Scholar
• Olsen, G.W., Church, T.R., Hansen, K.J., Burris, J.M., Butenhoff, J.L., Mandel, J.H., and Zobel, L.R. (2004b). Quantitative evaluation of perfluorooctanesulfonate (PFOS) and other fluorochemicals in the serum of children. J. Children’s Health 2:1–24.
   Google Scholar
• Olson, C.T., and Andersen, M.E. (1983). The acute toxicity of perfluorooctanoic and perfluorodecanoic acids in male rats and effects on tissue fatty acids. Toxicol. Appl. Pharmacol. 70:362–372.
   PubMed Web of Science ®Google Scholar
• Omar, M.A., Wilson, J.P., and Cox, T.S. (2001). Rhabdomyelosis and HMG-CoA reductase inhibitors. Ann. Pharmacother. 35:1096–1107.
   PubMed Web of Science ®Google Scholar
• Ophaug, R.H., and Singer, L. (1980). Metabolic handling of perfluorooctanoic acid in rats. Proc. Soc. Exp. Biol. Med. 163:19–23.
   PubMed Web of Science ®Google Scholar
• Palmer, C.N.A., Hsu, M.H., Griffin, K.J., Raucy, J.L., and Johnson, E.F. (1998). Peroxisome proliferator activated receptor-(*) expression in human liver. Mol. Pharmacol. 53:14–22.
   PubMed Web of Science ®Google Scholar
• Panaretakis, T., Shabalina, I.G., Grander, D., Shoshan, M.C., and DePierre, J.W. (2001). Reactive oxygen species and mitochondria mediate the induction of apoptosis in human hepatoma HepG2 cells by the rodent peroxisome proliferator and hepatocarcinogen, perfluorooctanoic acid. Toxicol. Appl. Phamacol. 173:56–64.
   PubMed Web of Science ®Google Scholar
• Pandol, S.J. (1998). Pancreatic physiology and secre-tory testing. In Gastrointestinal and liver diseases, vol. 1, eds. M. Sleisenger and J.S. Fordtran, pp.771–782. Philadelphia: W.B. Saunders.
   Google Scholar
• Pastoor, T.P., Lee, K.P., Perri, M.A., and Gillies, P.J. (1987). Biochemical and morphological studies of ammonium perfluorooctanoate-induced hepatomegaly and peroxisome proliferation. Exp. Mol. Pathol. 47:98–109.
   PubMed Web of Science ®Google Scholar
• Perkins, R.G. (1992). Investigation of ammonium perfluorooctanoate effect on hormone levels and peroxisomal proliferation in the rat. Toxicologist 12:52.
   Google Scholar
• Permadi, H., Lundgren, B., Andersson, K., and DePierre, J.W. (1992). Effects of perfluoro fatty acids on xenobiotic metabolizing enzymes which detoxify reactive forms of oxygen and lipid peroxidation in mouse liver. Biochem. Pharmacol. 44:1183–1191.
   PubMed Web of Science ®Google Scholar
• Peters, J.M., Cattley, R.C., and Gonzales, F.J. (1997). Role of PPAR(*) in the mechanism of action of the non-genotoxic carcinogen WY-14643. Carcinogenesis 18:2029–2033.
   PubMed Web of Science ®Google Scholar
• Peterson, R.E., Kuslikis, B.I., and Vanden Heuvel, J.P. (1991). Protein acylation by the peroxisome proliferators perfluorodecanoic acid (PFDA) and perfluorooctanoic acid (PFOA) in rats. Toxicologist 11:185.
   Google Scholar
• Pugh, G., Isenberg, J.S., Kamendolis, L.M., Ackley, D.C., Clare, L.J., Brown, R., Lington, A.W., Smith, J.H., and Klaasen, J.E. (2000). Effects of di-isononyl phthalate, di-2-ethylhexyl phthalate and clofibrate in cynomologus monkeys. Toxicol. Sci. 56:181–188.
   PubMed Web of Science ®Google Scholar
• Reddy, J.K., and Rao, M.S. (1977). Malignant tumors in rats fed nafenopin, a hepatic peroxisome proliferator. J. Natl. Cancer Inst. 59:1645–1650.
   PubMed Web of Science ®Google Scholar
• Reddy, J.K., and Rao, M.S. (1995). Postulated mechanisms of carcinogenicity mediated by peroxi-some proliferators. IARC Technical Report No. 24, pp. 41–53. Lyon, France.
   Google Scholar
• Riker. (1981). Final Report: Repeat Application 28-Day Percutaneous Absorption Study with T-2618 CoC in Albino Rabbits. Riker Laboratories Report 09790AB0485, March 15, 1981. U.S. EPA Public Docket AR-226-0446, Washington, DC.
   Google Scholar
• Riker. (1987). Two year oral (diet) toxicity/carcinogenicity study of fluorochemical FC-143 in rats. Riker Laboratories, Inc., Experiment No. 0281CR0012, August 29, 1987. U.S. EPA Public Docket AR-226-0437, Washington, DC.
   Google Scholar
• Ronnekleiv, O.K., Ojeda, S.R., and McCann, S.M. (1978). Undernutrition, puberty, and the development of estrogen positive feedback in the female rat. Biol. Reprod. 19:414–424.
   PubMed Web of Science ®Google Scholar
• Schottenfeld, D. (1996). Testicular cancer. In Cancer epidemiology and prevention, eds. D. Schottenfeld and J.F. Fraumeni, pp. 1207–1219. New York: Oxford University Press.
   Google Scholar
• Sohlenius, A.K., Andersson, K., and DePierre, J. (1992). The effects of perfluorooctanoic acid on hepatic peroxisome proliferation and related parameters show no sex-related differences in mice. Biochem. J. 265:779–783.
   Google Scholar
• Staples, R.E. (1985). Improper interpretation of data concerning teratogenicity: A case report. In Prevention of physical and mental congenital defects, Part C: Basic and medical science, education and Future strategies, pp. 161–163. New York: Alan R. Liss, Inc.
   Google Scholar
• Staples, R.E., Burgess, B.A., and Kerns, W.D. (1984). The embryo-fetal toxicity and teratogenic potential of ammonium perfluorooctanoate (APFO) in the rat. Fundam. Appl. Toxicol. 4:429–440.
   PubMedGoogle Scholar
• Starkov, A.A., and Wallace, K.B. (2002). Structural determinants of fluorochemical-induced mitochondrial dysfunction. Toxicol. Sci. 66:244–252.
   PubMed Web of Science ®Google Scholar
• Stoker, T.E., Laws, S.C., Guidici, D.L., and Cooper, R.L. (2000a). The effect of atrazine on puberty in male wistar rats: An evaluation in the protocol for assessment of pubertal development and thyroid function. Toxicol. Sci. 58:50–59.
   PubMed Web of Science ®Google Scholar
• Stoker, T.E., Parks, L.G., Gray, L.E., and Cooper, R.L. (2000b). Endocrine-disrupting chemicals: Prepubertal exposures and effects on sexual maturation and thyroid function in the male rat. A focus on the EDSTAC recommendations. Crit. Rev. Toxicol. 30:197–252.
   PubMed Web of Science ®Google Scholar
• Stone Research Laboratories. (1981). An assay of cell transformation and cytotoxicity in the C3H 10T 1/2 clonal cell line for the test chemical T-2942 CoC. Environmental Pathology Laboratory, Stone Research Laboratories, University of Minnesota, March 5, 1981. U.S. EPA Public Docket AR-226-0428, Washington, DC.
   Google Scholar
• Svoboda, D.J., and Azarnoff, D.L. (1979). Tumors in male rats fed ethyl chlorophenoxyisobutyrate, a hypolipidemic drug. Cancer Res. 39:3419–3428.
   PubMed Web of Science ®Google Scholar
• Takagi, A., Sai, K., Umemura, T., Hasegawa, R., and Kurokawa, Y. (1991). Short-term exposure to the peroxisome proliferators, perfluorooctanoic acid and perfluorodecanoic acid, causes significant increase of 8-hydroxydeoxyguanosine in liver DNA of rats. Cancer Lett. 57:55–60.
   PubMed Web of Science ®Google Scholar
• Takagi, A., Sai, K., Ummemura, T., Hasegawa, R., and Kurokawa, Y. (1992). Hepatomegaly is an early biomarker for hepatocarcinogenesis induced by peroxisome proliferators. J. Environ. Toxicol. Pathol. 11:145–149.
   Google Scholar
• Taves, D. (1968a). Evidence that there are two forms of fluorine in human serum. Nature 217:1050–1051.
   PubMed Web of Science ®Google Scholar
• Taves, D. (1968b). Electrophoretic mobility of serum fluoride. Nature 220:582–583.
   PubMedGoogle Scholar
• Taves, D., Guy, W., and Brey, W. (1976). Organic fluoro-carbons in human plasma: Prevalence and characterization. In Biochemistry involving carbon-fluorine bonds, ed. R. Filler, pp. 117–134. Washington, DC: American Chemical Society.
   Google Scholar
• Toxicon. (2002). CHO/HGPRT Forward mutation assay—ISO Toxicon Final Report: 01-7019-G1. U.S. EPA Public Docket AR-226-1101, Washington, DC.
   Google Scholar
• Tucker, M.J., and Orton, T.C. (1993). Toxicological studies in primates with three fibrates. In Peroxisomes: Biology and importance in toxicology and medicine, eds. G. Gibson and B. Lake, pp. 425–447. London: Taylor & Francis.
   Google Scholar
• Ubel, F.A., Sorenson, S.D., and Roach, D.E. (1980). Health status of plant workers exposed to fluorochemicals-a preliminary report. Am. Ind. Hyg. Assoc. J. 41:584–589.
   PubMed Web of Science ®Google Scholar
• Ullrich, V., and Diehl, H. (1971). Uncoupling of monooxygenation and electron transport by fluorocarbons in liver microsomes. Eur. J. Biochem. 20:509–512.
   PubMedGoogle Scholar
• Upham, B.L., Deocampo, N.D., Wurl, B., and Trosko, J.E. (1998). Inhibition of gap junctional intercellular communication by perfluorinated fatty acids is dependent on the chain length of the fluorinated tail. Int. J. Cancer 78:491–495.
   PubMed Web of Science ®Google Scholar
• Vanden Heuvel, J.P. (1999). Peroxisome proliferator-activated receptors (PPARs) and carcinogenesis. Toxicol. Sci. 47:1–8.
   PubMed Web of Science ®Google Scholar
• Vanden Heuvel, J., Kuslikis, B., and Van Rafelghem, M. (1991). Tissue distribution, metabolism, and elimination of perfluorooctanoic acid in male and female rats. Biochem. Toxicol. 6:83–92.
   PubMedGoogle Scholar
• Vanden Heuvel, J.P., Kuslikis, B.I., and Peterson, R.E. (1992a). Covalent binding of perfluorinated fatty acids to proteins in the plasma, liver and testes of rats. Chem.-Biol. Interact. 82:317–328.
   PubMed Web of Science ®Google Scholar
• Vanden Heuvel, J., Davis, J., Sommers, R., and Peterson, R. (1992b). Renal excretion of perfluorooctanoic acid in male rats: Inhibitory effect of testosterone. Biochem. Toxicol. 7:31–36.
   PubMedGoogle Scholar
• Ward, J.M., Peters, J.M., Perella, C.M., and Gonzalez, F.J. (1998). Receptor and non-receptor-mediated organ-specific toxicity of di(2-ethylhexyl) phtha-late (DEHP) in peroxisome proliferator-activated receptor (*)-null mice. Toxicol. Pathol. 26:240–246.
   PubMed Web of Science ®Google Scholar
• Widdowson, E.M., and McCance, R.A. (1960). Some effects of accelerating growth. I. General somatic development. Proc. R. Soc. B 152:188–206.
   PubMed Web of Science ®Google Scholar
• Yang, Q., Xie, Y., and DePierre, J.W. (2000). Effects of peroxisome proliferators in the thymus and spleen of mice. Clin. Exp. Immunol. 122:219–226.
   PubMed Web of Science ®Google Scholar
• Yang, Q., Xie, Y., Ericksson, A.M., Nelson, B.D., and DePierre, J.W. (2001). Further evidence for the involvement of inhibition of cell proliferation and development in thymic and splenic atrophy induced by the peroxisome proliferator perfluorooctanoic acid in mice. Biochem. Pharmacol. 62:1133–1140.
   PubMed Web of Science ®Google Scholar
• Yang, Q., Xie, Y., Alexson, S.E.H., Nelson, B.D., and DePierre, J.W. (2002a). Involvement of the peroxisome proliferator-activated receptor alpha in the immunomodulation caused by peroxisome proliferators in mice. Biochem. Pharmacol. 63:1893–1900.
   PubMed Web of Science ®Google Scholar
• Yang, Q., Abedi-Valugerdi, M., Xie, Y., Zhao, X., Moller, G., Nelson, B.D., and DePierre, J.W. (2002b). Potent suppression of the adaptive immune response in mice upon dietary exposure to the potent peroxisome proliferator, perfluorooctanoic acid. Int. Immunopharmacol. 2:389–397.
   PubMed Web of Science ®Google Scholar
• Ylinen, M., Hanhijärvi, H., Jaakonaho, J., and Peura, P. (1989). Stimulation by oestradiol of the urinary excretion of perfluorooctanoic acid in the male rat. Pharmacol. Toxicol. 65:274–277.
   PubMedGoogle Scholar
• Ylinen, M., Kojo, A., Hanhijärvi, H., and Peura, P. (1990). Deposition of perfluorooctanoic acid in the rat after single and subchronic administration. Bull. Environ. Contam. Toxicol. 44:46–53.
   PubMed Web of Science ®Google Scholar